Here are the 10-K annual reports from Healthy Extracts Inc (HYEX) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow HYEX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full HYEX filings page.
Healthy Extracts Inc. files its annual report outlining a nutraceutical platform focused on heart, brain, immune and gummy-based delivery products, including the 2025 acquisition of Gummy USA, now HE Gummy USA.
The company remains unprofitable, with a cumulative net loss of $20,121,462 from inception to December 31, 2025 and cash of $146,935, leading auditors to raise substantial doubt about its ability to continue as a going concern. As of March 31, 2026, non‑affiliate equity had an aggregate market value of $4,083,170, based on a $2.00 share price and 16,890,868 common shares outstanding.
Management highlights high gross margins of roughly 60%–70%, a differentiated Citrus Bergamot ingredient with higher BPF potency than key competitors, patented brain-health formulations, and an exclusive gel-pack delivery agreement with GELS. Growth plans center on new products (gut health, hydration, weight management), expanded sales channels, influencer partnerships and further strategic acquisitions, while acknowledging intense competition, supplier concentration, regulatory risks and the need for additional financing.